Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 0.34 |
| ▸ | KIF11 | P52732 | 2/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21399706 | 0.96 | KIF11 (0.34) | ELANEKIF11PTGER4PTGDR2AR | |
| SCHEMBL21399464 | 0.95 | KIF11 (0.36) | ELANEKIF11PTGDR2ARHCRTR1 | |
| SCHEMBL22985352 | 0.94 | ALOX5AP (0.35) | ELANEKIF11PTGER4PTGDR2AR | |
| SCHEMBL20849071 | 0.94 | AR (0.35) | ELANEKIF11PTGER4PTGDR2AR | |
| SCHEMBL21399461 | 0.93 | AR (0.41) | ELANEKIF11PTGER4PTGDR2AR | |
| SCHEMBL20848812 | 0.92 | AR (0.35) | ELANEKIF11PTGER4ARHCRTR1 | |
| SCHEMBL20849227 | 0.92 | PTGER4 (0.33) | ELANEPTGER4AR | |
| SCHEMBL22985487 | 0.92 | ALOX5AP (0.36) | ELANEKIF11PTGER4PTGDR2AR | |
| SCHEMBL21399715 | 0.92 | KIF11 (0.34) | ELANEKIF11PTGER4PTGDR2RORC | |
| SCHEMBL21399576 | 0.92 | KIF11 (0.37) | ELANEKIF11PTGER4PTGDR2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292151-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292151-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NR2E3, FOXO3 | ELANE 3696/4885KIF11 4281/4885PTGER4 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.